University of Rochester – Phase 4 Study

University of Rochester – Phase 4 Study

University of Rochester Seeks Participants for Final Validation Study of a New Lysosomal Acid Lipase Deficiency (LAL-D) Assessment Tool The University of Rochester (United States) is conducting the final phase of a research study aimed at developing and validating the...
A New Research Model for Lysosomal Acid Lipase Deficiency (LAL-D)

A New Research Model for Lysosomal Acid Lipase Deficiency (LAL-D)

LIPA c.894G>A: From Patients to Models A study recently accepted for publication in Scientific Reports describes the first mouse model carrying the LIPA c.894G>A (E8SJM) mutation, the most common genetic variant associated with the later-onset form of Lysosomal...
“Lipids and Health” Conference

“Lipids and Health” Conference

“Lipids and Health” Conference: Early Diagnosis, Multidisciplinary Care and Access to Treatment https://lald.org/wp-content/uploads/2026/07/Jornada-Lipidos-y-Salud.mp4   On June 30, the Faculty of Medicine of the University of Barcelona hosted the “Lipids and...
“Lipids and Health” Conference

“Lipids and Health” Conference

“Lipids and Health” Conference Next June 30 at 5:00 p.m., Cardioalianza, LAL-D Patient Organization, ASCAHIFA and Asociación Síndrome Quilomicronemia Familiar organizamos en Barcelona la jornada “Lípidos y salud”, are organizing in Barcelona the “Lipids...
EASL and ELPA AGM 2026 in Barcelona

EASL and ELPA AGM 2026 in Barcelona

EASL Congress 2026: Barcelona at the heart of hepatology From May 26–29, Barcelona hosted the EASL Congress 2026, one of the leading international events in hepatology, bringing together healthcare professionals, researchers, and key stakeholders in liver health. Over...